Could a nasal spray boost PTSD therapy? small study explores the idea
NCT ID NCT06795659
First seen Jan 29, 2026 · Last updated May 01, 2026 · Updated 11 times
Summary
This early-phase study tested whether adding esketamine (a nasal spray approved for depression) to prolonged exposure therapy could help reduce PTSD symptoms. Only 4 adults with PTSD took part. The main goal was to see if the combination was feasible and acceptable, not to prove it works. Results are limited due to the very small size.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POST TRAUMATIC STRESS DISORDER PTSD are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
The University of Texas Health Science Center at San Antonio
San Antonio, Texas, 78229, United States
Conditions
Explore the condition pages connected to this study.